If a single class of medications can meaningfully address both metabolic and addictive disorders, it challenges us to rethink the boundaries between these fields
It might mean your injection timing needs adjustment
In a report published in November, 2023, based on data collected between 2015 and 2022, an estimated 30% of Canadian adults were classified as obese based on BMI measures (i.e., BMI greater than 30)
By activating both GIP and GLP-1 receptors, tirzepatide enhances insulin secretion when blood glucose levels are elevated, suppresses inappropriate glucagon release, slows gastric emptying, and reduces appetite through effects on brain centers that regulate food intake
The triple agonist approach creates what researchers describe as a metabolic triple threat
A friend suggested I look into Neurobion Forte Injection